A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells-Reference-Cited by-同舟云学术

A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells

Published:2021-03-31 Issue:4 Volume:16 Page:642-650
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Mellott Drake M.^ORCID,Tseng Chien-Te¹,Drelich Aleksandra¹,Fajtová Pavla²³,Chenna Bala C.^ORCID,Kostomiris Demetrios H.,Hsu Jason¹,Zhu Jiyun,Taylor Zane W.,Kocurek Klaudia I.,Tat Vivian¹,Katzfuss Ardala,Li Linfeng^ORCID,Giardini Miriam A.²,Skinner Danielle²,Hirata Ken²,Yoon Michael C.²,Beck Sungjun²,Carlin Aaron F.⁴,Clark Alex E.²,Beretta Laura²,Maneval Daniel,Hook Vivian²^ORCID,Frueh Felix,Hurst Brett L.,Wang Hong,Raushel Frank M.^ORCID,O’Donoghue Anthony J.²^ORCID,de Siqueira-Neto Jair Lage²,Meek Thomas D.^ORCID,McKerrow James H.²^ORCID

Affiliation:

1. Department of Microbiology and Immunology, University of Texas, Medical Branch, 3000 University Boulevard, Galveston, Texas 77755-1001, United States

2. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093, United States

3. Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 16610 Prague, Czech Republic

4. Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California 92037, United States

Funder

National Institute of Allergy and Infectious Diseases

Burroughs Wellcome Fund

Selva Therapeutics, Inc.

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acschembio.0c00875

Reference42 articles.

1. A pneumonia outbreak associated with a new coronavirus of probable bat origin